← All companies

AURA

Aura Biosciences, Inc.

AURA Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$7.15

+0.11 +1.56%

Key statistics

from XBRL data in SEC filings

Market cap

$739M

Revenue (TTM)

—

Net income (TTM)

-$112M

EPS (TTM)

$-1.71

P/E ratio

—

Dividend yield

—

Free cash flow

-$85.2M

Cash

$84.8M

Total assets

$138M

Gross margin

—

52-week range

$4.73 – $9.54

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Director or officer change Jul 8, 2026 8-K Shareholder vote results Jun 11, 2026 10-Q Quarter ended 2026-03-31 May 11, 2026 8-K Results of operations (earnings release); Other events May 11, 2026 8-K Entered a material agreement May 5, 2026 8-K Entered a material agreement; Results of operations (earnings release); Other events May 4, 2026 8-K Director or officer change; Regulation FD disclosure; Other events May 4, 2026 10-K Fiscal year ended 2025-12-31 Mar 30, 2026 8-K Results of operations (earnings release); Other events Mar 30, 2026 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Results of operations (earnings release); Other events Nov 13, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Results of operations (earnings release); Other events Aug 13, 2025 8-K Shareholder vote results Jun 18, 2025 8-K Entered a material agreement; Other events May 16, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Results of operations (earnings release); Director or officer change May 15, 2025 8-K Director or officer change Apr 2, 2025 10-K Fiscal year ended 2024-12-31 Mar 24, 2025 8-K Results of operations (earnings release); Other events Mar 24, 2025 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release); Other events Nov 12, 2024 8-K Regulation FD disclosure; Other events Oct 17, 2024 8-K Director or officer change Sep 27, 2024 8-K Regulation FD disclosure; Other events Sep 12, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release); Other events Aug 8, 2024 8-K Amended charter or bylaws; Shareholder vote results Jun 21, 2024 10-K/A Fiscal year ended 2023-12-31 Jun 14, 2024 8-K Other events Jun 4, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release) May 9, 2024 8-K Director or officer change Apr 15, 2024 10-K Fiscal year ended 2023-12-31 Mar 27, 2024 8-K Results of operations (earnings release) Mar 27, 2024 8-K Other events Jan 8, 2024 10-Q Quarter ended 2023-09-30 Nov 9, 2023 8-K Entered a material agreement; Results of operations (earnings release) Nov 9, 2023 8-K Regulation FD disclosure; Other events Nov 6, 2023 8-K Director or officer change Oct 2, 2023